DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France

Autor: Maria Pia Sormani, Marco Salvetti, Pierre Labauge, Irene Schiavetti, Helene Zephir, Luca Carmisciano, Caroline Bensa, Nicola De Rossi, Jean Pelletier, Cinzia Cordioli, Sandra Vukusic, Lucia Moiola, Philippe Kerschen, Marta Radaelli, Marie Théaudin, Paolo Immovilli, Olivier Casez, Marco Capobianco, Jonathan Ciron, Maria Trojano, Bruno Stankoff, Alain Créange, Gioacchino Tedeschi, Pierre Clavelou, Giancarlo Comi, Eric Thouvenot, Mario Alberto Battaglia, Thibault Moreau, Francesco Patti, Jérôme De Sèze, Celine Louapre, the Musc‐, the Covisep study groups

Publikováno v: Annals of Clinical and Translational Neurology, Vol 8, Iss 8, Pp 1738-1744 (2021)

Abstract We evaluated the effect of DMTs on Covid‐19 severity in patients with MS, with a pooled‐analysis of two large cohorts from Italy and France. The association of baseline characteristics and DMTs with Covid‐19 severity was assessed by mu

Externí odkaz: https://doaj.org/article/dc03cd08037d4f2191d0b6ce786e866a

Association of Posterior Reversible Encephalopathy Syndrome and Transient Apical Ballooning Syndrome (Takotsubo): First Case Report of a Man and Review of the Literature

Autor: Stephan Grimaldi, Emilie Doche, Caroline Rey, Nadia Laksiri, Salah Boussen, Jacques Quilici, Emmanuelle Robinet, Fabien Devemy, Jean Pelletier

Publikováno v: Case Reports in Neurology, Vol 9, Iss 2, Pp 173-178 (2017)

Introduction: An association of posterior reversible encephalopathy syndrome (PRES) and takotsubo is rare. We present the first case of a male patient. Case Report: A 69-year-old man presented to the hospital in a persistent comatose state following

Externí odkaz: https://doaj.org/article/af2cd3f2a0ef438d83f77262502bcb86

Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system

Autor: Camille Sabathé, Romain Casey, Sandra Vukusic, Emmanuelle Leray, Guillaume Mathey, Jérôme De Sèze, Jonathan Ciron, Sandrine Wiertlewski, Aurélie Ruet, Jean Pelletier, Hélène Zéphir, Laure Michel, Christine Lebrun-Frenay, Xavier Moisset, Eric Thouvenot, Jean-Philippe Camdessanché, Serge Bakchine, Bruno Stankoff, Abdullatif Al Khedr, Philippe Cabre, Elisabeth Maillart, Eric Berger, Olivier Heinzlef, Karolina Hankiewicz, Thibault Moreau, Olivier Gout, Bertrand Bourre, Abir Wahab, Pierre Labauge, Alexis Montcuquet, Gilles Defer, Aude Maurousset, Nicolas Maubeuge, Dalia Dimitri Boulos, Haïfa Ben Nasr, Chantal Nifle, Olivier Casez, David-Axel Laplaud, Yohann Foucher

Publikováno v: Multiple Sclerosis Journal
Multiple Sclerosis Journal, 2023, 29 (2), pp.236-247. ⟨10.1177/13524585221139156⟩

Background: In relapsing-remitting multiple sclerosis (RRMS), early identification of suboptimal responders can prevent disability progression. Objective: We aimed to develop and validate a dynamic score to guide the early decision to switch from fir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb0d295f009630c7a4453984a4cacd15
https://amu.hal.science/hal-04086418

Untreated patients with multiple sclerosis: A study of French expert centers

Autor: Xavier Moisset, Bruno Stankoff, Pierre Clavelou, Karolina Hankiewicz, Bruno Brochet, Olivier Casez, Bruno Pereira, Chantal Nifle, Thibault Moreau, Sandra Vukusic, Christine Lebrun-Frenay, Eric Thouvenot, Alain Créange, Olivier Gout, Corinne Pottier, Olivier Heinzlef, Caroline Papeix, Gilles Defer, Eric Berger, David Laplaud, Audrey-Anne Fouchard, S. Bakchine, Alexis Montcuquet, Jean Pelletier, Jérôme De Seze, Dalia Dimitri Boulos, Jean-Philippe Camdessanché, Pierre Labauge, Bertrand Bourre, Philippe Cabre, Abdullatif Al-Khedr, Aude Maurousset, Frederic Taithe, Gilles Edan, Jonathan Ciron, Nicolas Maubeuge, Guillaume Mathey, Patrick Vermersch

Publikováno v: European Journal of Neurology
European Journal of Neurology, 2021, 28 (6), pp.2026-2036. ⟨10.1111/ene.14790⟩
European Journal of Neurology, Wiley, 2021, 28 (6), pp.2026-2036. ⟨10.1111/ene.14790⟩

International audience; Background and purpose: Disease-modifying therapies (DMTs) have an impact on relapses and disease progression. Nonetheless, many patients with multiple sclerosis (MS) remain untreated. The objectives of the present study were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7aef750070852e10487d85e1fd5181
https://doi.org/10.1111/ene.14790

[Current management of multiple sclerosis]

Autor: Adil, Maarouf, Bertrand, Audoin, Jean, Pelletier

Publikováno v: La Revue du praticien. 72(4)

"Current management of multiple sclerosis Significant advances has been made in the management of MS patients. The treatment of relapses is well codified, and highly effective disease-modifying therapies target the inflammatory component in relapsing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8a9bacf2c802da43a999afda20003e6f
https://pubmed.ncbi.nlm.nih.gov/35638983